Page 1212 - Basic _ Clinical Pharmacology ( PDFDrive )

1198 Index

Carvedilol, 160, 164t, 166, 170t, 191t. heart failure, 212, 227 Cathartics, for toxin elimination, 1040
See also b-receptor antagonist heterozygous familial Catumaxomab, 992
drugs hypercholesterolemia, 626, 641 Causal prophylactic drugs, for malaria, 917
dissociation constants and enantiomers HIV and tuberculosis, antimycobacterial CB1 receptors, brain, 377t, 380
of, 4, 4t drugs for, 842, 852 CD8 T lymphocytes, 979f, 980
heart failure treated with, 221, 222, 225t HIV plus HBV treatment, in alcoholic Cefaclor, 802f
hypertension treated with, 183 smoker on methadone, 863, 894 Cefadroxil, 802f
Cascara, 1099 hydrocortisone, 719 Cefazolin, 802f, 803t
Case-control epidemiologic studies, 15b hypertension, 173, 193 Cefdinir, 802f
Case reports, 14b with Alzheimer’s and age-related Cefepime, 802f, 803t
Case series, 14b macular degeneration, 1058, 1067 Cefotaxime, 802f, 803t
Case studies renin-angiotensin system suppression Cefotetan, 802f, 803t
acetaminophen safety, 56, 73 for, 300, 320 Cefoxitin, 802f, 803t
acute myelogenous leukemia, 977, 1001 insulin, 747, 771 Cefpodoxime, 802f
alcohol poisoning, acute, 396, 408 marijuana, 575, 589 Cefprozil, 802f
amoxicillin, rash from, 795, 814 megaloblastic anemia, vitamin B 12 Ceftaroline, 802f
anesthesia, 440, 459, 473 deficiency, 591, 607 Ceftazidime, 802f, 803t
antiseizure drugs, 409, 439 muscle relaxants, for emergency trauma Ceftazidime-avibactam, 803t
aspirin overdose, 1, 19 surgery, 491 Ceftazidime-tazobactam, 803t
asthma, respiratory infection on, 346, opioids, 553, 574 Ceftibuten, 802f
365 organophosphate cholinesterase inhibitor Ceftolozane R 1 , 802f
atazanavir, 74, 87 poisoning, 107, 123 Ceftriaxone, 802f, 803t
atrial fibrillation and left ventricular osteoporosis, 772, 791 Cefuroxime, 802f, 803t
dysfunction, 228, 253 pheochromocytoma, 156, 172 Cefuroxime axetil, 804
autonomic failure, pure, 137, 155 propranolol, 20, 40 Celecoxib, 645t, 647
bacterial food poisoning, 1034 pulmonary hypertension, 321, 338 Celiprolol, 164t, 166, 170t. See also
blepharospasm, 106 rheumatoid arthritis, 642, 666 b-receptor antagonist drugs
botulinum toxin, 89, 106 schizophrenia, 511, 531 Cell-mediated immunity, 979
bupropion overdose, seizure management sleep problems, 381, 395 Cell wall, bacterial, 797, 797f
in, 1035, 1047 tetracyclines, 815, 825 Central integration, autonomic, 91f, 100,
Clostridium difficile, 895, 903 tobramycin, 831, 833 101t, 103
cold medications, hypertension from, toxicology, 1003 Central nervous system (CNS), 89,
1120, 1130 urinary frequency and incontinence after 367–373
colorectal cancer stage III, chemotherapy prostatectomy, 124, 136 alcohol effects on, 398
for, 948, 976 urinary tract infection, antibiotic choice angiotensin II on, 304
community-acquired pneumonia and in, 834, 841 brain cellular organization in
meningitis, cephalosporin and verapamil, 20, 40 hierarchical systems in, 373, 373f
vancomycin for, 795, 814 Caspofungin, 859, 861t nonspecific or diffuse neuronal
coronary artery disease, 194, 211 Catatonic schizophrenia, antipsychotics systems in, 373–374, 374f
Crohn’s disease treatment, 1087, 1119 for, 518. See also Antipsychotic contraceptives on, female hormonal, 733
deep venous thrombosis, heparin for agents fundamentals of, 368
pulmonary embolism from, 608, Catechol, 144f ion channels and neurotransmitter
625 Catecholamine receptors receptors in, 369f, 369–370, 370t
digoxin, 41, 55 agonists binding to, 139, 140f lead exposure effects on, 1022
dihydropyrimidine dehydrogenase structure of, 144f methylxanthines effect on, 352–353
enzyme deficiency, 976 Catecholamine reuptake inhibitors, 143f, organization of
diuretics, acute kidney injury from 151 blood–brain barrier, 368–369
chronic use of, 254, 275 Catecholaminergic polymorphic ventricular neuroglia, 368, 368f
drugs of abuse, 575, 589 tachycardia, 234b neurons, 368, 368f
eicosanoids, 321, 338 Catecholamines. See also specific types sites of drug action in, 371–373, 373f
enalapril, 300 biosynthesis of, 95, 97f sympathomimetics on, 148
epilepsy (Seizures), 409, 439 endogenous, 146f, 146t, 148–149 synapses and synaptic potential in,
falciparum malaria treatment, 917, 937 metabolism of, 96–97, 98f 370–371, 371f
fluoxetine for depression, CYP450 and Catechol-O-methyltransferase (COMT), Central nervous system (CNS) drugs, in
pharmacodynamic interactions 142–143 elderly, 1061–1063
of, 532, 552 catecholamine metabolism by, 98f Alzheimer’s disease, 1062f, 1062–1063,
food poisoning, 1034 inhibitors of, for parkinsonism, 500, 1063t
growth hormone deficiency, 667, 686 508t analgesics, 1061